Peabody, J.; Paculdo, D.; Tamondong-Lachica, D.; Cabaluna, I.T.; Gunn, J.
Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain. Diagnostics 2020, 10, 513.
https://doi.org/10.3390/diagnostics10080513
AMA Style
Peabody J, Paculdo D, Tamondong-Lachica D, Cabaluna IT, Gunn J.
Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain. Diagnostics. 2020; 10(8):513.
https://doi.org/10.3390/diagnostics10080513
Chicago/Turabian Style
Peabody, John, David Paculdo, Diana Tamondong-Lachica, Ian Theodore Cabaluna, and Joshua Gunn.
2020. "Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain" Diagnostics 10, no. 8: 513.
https://doi.org/10.3390/diagnostics10080513
APA Style
Peabody, J., Paculdo, D., Tamondong-Lachica, D., Cabaluna, I. T., & Gunn, J.
(2020). Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain. Diagnostics, 10(8), 513.
https://doi.org/10.3390/diagnostics10080513